Get the tools used by (smart)2 investors.

EPS Forecast (FINBOX) for Glaukos Corp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

GKOS: Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and int...

86.07 USD
Price
USD
Fair Value
Upside
77.91 - 163.71
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Glaukos Corp's EPS Forecast (FINBOX):

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20342610

Performance Summary
  • Glaukos's eps forecast for the next fiscal year is -0.94
  • Glaukos's eps forecast is expected to average 1.01 over the next 5 fiscal years.
  • Glaukos's is expected to deliver median eps forecast of 0.68 over the next 5 fiscal years.

How does Glaukos Corp's EPS Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Glaukos Corp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EPS Forecast

Hide this widget
eps_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EPS Forecast (FINBOX) in the forecast category include:

View Full List

Search for metric or datapoint

EPS Forecast

Forecasted earnings per share (EPS).

Definition of EPS Forecast (FINBOX)

Hide this widget
Forecasted earnings per share (EPS).

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-14.38-6.381.6216.430200400

The chart above depicts the distribution of eps forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,000 companies were considered in this analysis, and 1,923 had meaningful values. The average eps forecast (finbox) of companies in the sector is -0.16 with a standard deviation of 3.21.

Glaukos Corp's EPS Forecast (FINBOX) of -0.94 ranks in the 27.0% percentile for the sector. The following table provides additional summary stats:

EPS Forecast (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,003
Included Constituents1,923
Min-14.67
Max16.07
Median-0.026
Mean-0.16
Standard Deviation3.21

You can find companies with similar eps forecast (finbox) using this stock screener.

All rights reserved. Terms Of Use